The aim is to investigate the effectiveness of exercise in the treatment of erectile dysfunction and premature ejaculation.

The study was designed as a randomized controlled trial. Participants were divided into two equal groups: a control group and an exercise group. Patients in the control group were followed with normal conventional medical treatment, while participants in the exercise group underwent an 8-week, 3-day-a-week exercise program. All participants were evaluated before and after treatment using the Index of Erectile Function, the World Health Organization Quality of Life Short Form, and the Premature Ejaculation Diagnostic Tool.

Inclusion Criteria

• Male individuals aged 25-45 years
• Individuals diagnosed with erectile dysfunction and premature ejaculation
• Individuals who voluntarily agree to participate in the study and sign the informed consent form
• Individuals who have the physical and cognitive capacity to participate in pelvic floor physiotherapy applications

Exclusion Criteria

• Individuals with a history of surgery in the pelvic region
• Individuals with a diagnosis of neurological disease or neurological disorder that may affect pelvic floor muscle function
• Presence of active infection, inflammation, or painful pathology in the pelvic region
• Individuals who regularly use medications that significantly affect sexual function
• Individuals with serious psychiatric illness or cognitive impairment that may hinder study compliance

diseases seen in men